Morbidity and Mortality According to Latest CD4+ Cell Count among HIV Positive Individuals in South Africa Who Enrolled in Project Phidisa

Patrick H Maduna, Matt Dolan, Lwando Kondlo, Honey Mabuza, Judith N Dlamini, Mike Polis, Thabo Mnisi, Susan Orsega, Patrick Maja, Lotty Ledwaba, Thuthukile Molefe, Phumelele Sangweni, Lisette Malan, Gugu Matchaba, Paul Khabo, Greg Grandits and James D Neaton

PLOS ONE, 2015, vol. 10, issue 4, 1-20

Abstract: Background: Short-term morbidity and mortality rates for HIV positive soldiers in the South African National Defence Force (SANDF) would inform decisions about deployment and HIV disease management. Risks were determined according to the latest CD4+ cell count and use of antiretroviral therapy (ART) for HIV positive individuals in the SANDF and their dependents. Methods and Findings: A total of 7,114 participants were enrolled and followed for mortality over a median of 4.7 years (IQR: 1.9, 7.1 years). For a planned subset (5,976), progression of disease (POD) and grade 4, potentially life-threatening events were also ascertained. CD4+ count and viral load were measured every 3 to 6 months. Poisson regression was used to compare event rates by latest CD4+ count (

Date: 2015
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0121843 (text/html)
https://journals.plos.org/plosone/article/file?id= ... 21843&type=printable (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:plo:pone00:0121843

DOI: 10.1371/journal.pone.0121843

Access Statistics for this article

More articles in PLOS ONE from Public Library of Science
Bibliographic data for series maintained by plosone ().